These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 23998955)

  • 1. Formulation, characterization and pharmacokinetics of Morin hydrate niosomes prepared from various non-ionic surfactants.
    Waddad AY; Abbad S; Yu F; Munyendo WL; Wang J; Lv H; Zhou J
    Int J Pharm; 2013 Nov; 456(2):446-58. PubMed ID: 23998955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Formulation and evaluation of metformin hydrochloride-loaded niosomes as controlled release drug delivery system.
    Hasan AA; Madkor H; Wageh S
    Drug Deliv; 2013; 20(3-4):120-6. PubMed ID: 23651102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physicochemical properties and skin permeation of Span 60/Tween 60 niosomes of ellagic acid.
    Junyaprasert VB; Singhsa P; Suksiriworapong J; Chantasart D
    Int J Pharm; 2012 Feb; 423(2):303-11. PubMed ID: 22155414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Formulation and in vitro assessment of minoxidil niosomes for enhanced skin delivery.
    Balakrishnan P; Shanmugam S; Lee WS; Lee WM; Kim JO; Oh DH; Kim DD; Kim JS; Yoo BK; Choi HG; Woo JS; Yong CS
    Int J Pharm; 2009 Jul; 377(1-2):1-8. PubMed ID: 19394413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Formulation and evaluation of niosomal nasal drug delivery system of folic acid for brain targeting.
    Ravouru N; Kondreddy P; Korakanchi D; Haritha M
    Curr Drug Discov Technol; 2013 Dec; 10(4):270-82. PubMed ID: 23863098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design and in vitro characterization of small unilamellar niosomes as ophthalmic carrier of dorzolamide hydrochloride.
    Hasan AA
    Pharm Dev Technol; 2014 Sep; 19(6):748-54. PubMed ID: 23964893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced ocular bioavailability of fluconazole from niosomal gels and microemulsions: formulation, optimization, and in vitro-in vivo evaluation.
    Soliman OAE; Mohamed EA; Khatera NAA
    Pharm Dev Technol; 2019 Jan; 24(1):48-62. PubMed ID: 29210317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and evaluation of nanosized niosomal dispersion for oral delivery of Ganciclovir.
    Akhter S; Kushwaha S; Warsi MH; Anwar M; Ahmad MZ; Ahmad I; Talegaonkar S; Khan ZI; Khar RK; Ahmad FJ
    Drug Dev Ind Pharm; 2012 Jan; 38(1):84-92. PubMed ID: 21726136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of proniosomes as an alternative strategy to optimize piroxicam transdermal delivery.
    Alsarra IA
    J Microencapsul; 2009 May; 26(3):272-8. PubMed ID: 18720197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characteristics and in vitro anti skin aging activity and UV radiation protection of morin loaded in niosomes.
    Mohamadi N; Soltanian S; Raeiszadeh M; Moeinzadeh M; Ohadi M; Sharifi F; Pardakhty A; Sharififar F
    J Cosmet Dermatol; 2022 Nov; 21(11):6326-6335. PubMed ID: 35876761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Niosomes vs microemulsions: new carriers for topical delivery of Capsaicin.
    Tavano L; Alfano P; Muzzalupo R; de Cindio B
    Colloids Surf B Biointerfaces; 2011 Oct; 87(2):333-9. PubMed ID: 21684725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent advances in non-ionic surfactant vesicles (niosomes): self-assembly, fabrication, characterization, drug delivery applications and limitations.
    Abdelkader H; Alani AW; Alany RG
    Drug Deliv; 2014 Mar; 21(2):87-100. PubMed ID: 24156390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of some formulation parameters on flurbiprofen encapsulation and release rates of niosomes prepared from proniosomes.
    Mokhtar M; Sammour OA; Hammad MA; Megrab NA
    Int J Pharm; 2008 Sep; 361(1-2):104-11. PubMed ID: 18577437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a novel niosomal system for oral delivery of Ginkgo biloba extract.
    Jin Y; Wen J; Garg S; Liu D; Zhou Y; Teng L; Zhang W
    Int J Nanomedicine; 2013; 8():421-30. PubMed ID: 23378764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mannosylated niosomes as adjuvant-carrier system for oral genetic immunization against hepatitis B.
    Jain S; Singh P; Mishra V; Vyas SP
    Immunol Lett; 2005 Oct; 101(1):41-9. PubMed ID: 15869802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sorbitane Monostearate and Cholesterol based Niosomes for Oral Delivery of Telmisartan.
    Ahad A; Raish M; Al-Jenoobi FI; Al-Mohizea AM
    Curr Drug Deliv; 2018 Feb; 15(2):260-266. PubMed ID: 28521674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Impact of Surfactant Composition and Surface Charge of Niosomes on the Oral Absorption of Repaglinide as a BCS II Model Drug.
    Yaghoobian M; Haeri A; Bolourchian N; Shahhosseni S; Dadashzadeh S
    Int J Nanomedicine; 2020; 15():8767-8781. PubMed ID: 33204087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of different types of surfactants on the physical properties and stability of carvedilol nano-niosomes.
    Taymouri S; Varshosaz J
    Adv Biomed Res; 2016; 5():48. PubMed ID: 27110545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation and characterization of niosomes containing ribavirin for liver targeting.
    Hashim F; El-Ridy M; Nasr M; Abdallah Y
    Drug Deliv; 2010 Jul; 17(5):282-7. PubMed ID: 20350052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alkyl glucopyranoside-based niosomes containing methotrexate for pharmaceutical applications: evaluation of physico-chemical and biological properties.
    Muzzalupo R; Tavano L; La Mesa C
    Int J Pharm; 2013 Dec; 458(1):224-9. PubMed ID: 24060370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.